SGMT Earnings

Quarterly EPS
$-0.45
Q3 2024
$-0.50
Q4 2024
$-0.56
Q1 2025
$-0.32
Q2 2025
$-0.40
Q3 2025
$-0.29
Q4 2025
$-0.33
Q1 2026
$-0.26
Q2 2026
Latest RevenueN/A
Latest Net Income-13953000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.260-13953000+18.8%
Q1 2026-$0.330-10650000+41.1%
Q4 2025-$0.290-9568000+42.0%
Q3 2025-$0.400-12908000+11.1%
Q2 2025-$0.320-10386000-28.0%
Q1 2025-$0.560-18176000-143.5%
Q4 2024-$0.500-16201000-42.9%
Q3 2024-$0.450-14619000-100.0%-28.6%
Q2 2024-$0.250-8118000
Q1 2024-$0.230-6629000
Q4 2023-$0.350-8151000
Q3 2023-$0.352.0M-6353000
Sagimet Biosciences (SGMT) — Earnings